SRX 1.41% 17.5¢ sierra rutile holdings limited

Ann: Sirtex Completes SIRFLOX Patient Recruitment, page-3

  1. 37 Posts.
    re: Ann: Sirtex Completes SIRFLOX Patient Rec... Agree it is nice to see the company finish recruitment to their first big trial. But they finished it when they said they would, as they usually seem to do. Note in their half year result they state that their trials are speeding up their recruitment ahead of expectation. This is very rare in the trials world.

    Important to correct you cafa. The FDA does not currently stipulate at what line of treatment sir-spheres should be used. A US physician is allowed to use them at any line of treatment. It won't matter a jot if FDA doesn't change the labeling in any way. The result of this study is only designed to convince oncologists to refer patients and to get sir-spheres into medical practice guidelines that dictate what physicians treat with.
 
watchlist Created with Sketch. Add SRX (ASX) to my watchlist
(20min delay)
Last
17.5¢
Change
-0.003(1.41%)
Mkt cap ! $74.27M
Open High Low Value Volume
17.5¢ 18.0¢ 17.5¢ $11.32K 63.24K

Buyers (Bids)

No. Vol. Price($)
14 6835717 17.5¢
 

Sellers (Offers)

Price($) Vol. No.
18.0¢ 1404477 13
View Market Depth
Last trade - 16.10pm 29/07/2024 (20 minute delay) ?
SRX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.